orbifloxacin has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC | 1 |
| Gaweda, B; Obmińska-Mrukowicz, B; Szczypka, M | 1 |
2 other study(ies) available for orbifloxacin and Escherichia coli Infections
| Article | Year |
|---|---|
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2012 |
Modulation of cellular immune response by orbifloxacin in noninfected and E. coli-infected mice.
Topics: Animals; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Interleukin-1; Macrophages, Peritoneal; Mice; Nitric Oxide; T-Lymphocyte Subsets; Thymus Gland | 2005 |